Table 4 Comparison of exclusive terms between patents and re-examinations
From: Lifecycle management of orphan drugs approved in Japan
Re-examination > patents | Re-examination < patents | Total | |
|---|---|---|---|
Total | 28 | 126 | 154 |
With extension | 22 | 103 | 125 |
No extension | 6 | 23 | 29 |